These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 24041692

  • 1. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
    Lee JC, Shin J, Baek KH.
    Biochem Biophys Res Commun; 2013 Oct 11; 440(1):50-5. PubMed ID: 24041692
    [Abstract] [Full Text] [Related]

  • 2. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J, Lee JC, Baek KH.
    Cancer Lett; 2014 Jan 01; 342(1):70-81. PubMed ID: 24051307
    [Abstract] [Full Text] [Related]

  • 3. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
    Maier HJ, Wagner M, Schips TG, Salem HH, Baumann B, Wirth T.
    Oncogene; 2013 May 23; 32(21):2690-5. PubMed ID: 22751123
    [Abstract] [Full Text] [Related]

  • 4. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R, Wang Q, Cheng S, Liu T, Jiang H, Zhu J, Wu Y, Wang L.
    Cancer Lett; 2013 Oct 01; 339(1):135-43. PubMed ID: 23887057
    [Abstract] [Full Text] [Related]

  • 5. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B, Heeschen C.
    Gastroenterology; 2014 Nov 01; 147(5):1119-33.e4. PubMed ID: 25127677
    [Abstract] [Full Text] [Related]

  • 6. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T, Ikehara S, Nakanishi H, Ikehara Y.
    J Pathol; 2014 Oct 01; 234(2):228-38. PubMed ID: 25042889
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S, Estivill X.
    Trends Mol Med; 2006 Oct 01; 12(10):451-4. PubMed ID: 16919501
    [Abstract] [Full Text] [Related]

  • 11. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
    Al Saati T, Clerc P, Hanoun N, Peuget S, Lulka H, Gigoux V, Capilla F, Béluchon B, Couvelard A, Selves J, Buscail L, Carrier A, Dusetti N, Dufresne M.
    Am J Pathol; 2013 Jun 01; 182(6):1996-2004. PubMed ID: 23578383
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L, Sanderson SO, Lloyd RV, Smyrk TC.
    Am J Surg Pathol; 2007 Aug 01; 31(8):1191-5. PubMed ID: 17667542
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE, Klug CA.
    Cancer Res; 2007 Sep 01; 67(17):8121-30. PubMed ID: 17804724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.